New Alzheimer's drug a hope for patients, but a worry for Doctors. For generations doctors have sought ways to enrich and extend the lives of Alzheimer’s patients. However, without credible medications to contend with this degenerative condition, they are left with merely accounting for symptoms and providing brain stimulation activities to extend the cognition of the patient for as long as possible. That was until now. The drug known as Aduhelm has proven remarkable in preliminary trials and has been approved by the FDA for distribution.